NCT03558009 (EHA) is a clinical trial in Abdominal Pain, sponsored by CENTOGENE GmbH Rostock.

Who is sponsoring NCT03558009?

NCT03558009 is sponsored by CENTOGENE GmbH Rostock.

What condition does NCT03558009 study?

NCT03558009 studies Abdominal Pain, Functional Abdominal Pain.

Is NCT03558009 still recruiting?

NCT03558009 is currently completed. Last updated 25 April 2022.

Last reviewed 2022-04-25 · How we verify

NCT03558009: EHA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Epidemiological Analysis for Hereditary Angioedema Disease

Completed Last updated 25 April 2022

What this trial tests

trial in Abdominal Pain in 2,318 participants. Completed in 11 April 2022.

Timeline

1 September 2018

Primary endpoint
11 April 2022

11 April 2022

Quick facts

Lead sponsor	CENTOGENE GmbH Rostock
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,318
Start date	1 September 2018
Primary completion	11 April 2022
Estimated completion	11 April 2022
Sites	35 locations across Italy, Japan, United Kingdom, Germany, Poland, Turkey (Türkiye)

Conditions studied

Abdominal Pain — all drugs for Abdominal Pain →
Functional Abdominal Pain — all drugs for Functional Abdominal Pain →

Sponsor

CENTOGENE GmbH Rostock

Who can join

Adults 2 to 60, any sex, with Abdominal Pain or Functional Abdominal Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An international, multicenter, epidemiological, observational study investigating the prevalence of Hereditary Angioedema (HAE) disease among participants with recurrent episodes of abdominal pain of no obvious etiology.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Deep Brain Stimulation for the Management of Refractory Neurological Disorders: A Comprehensive Review.
Rissardo JP, Vora NM, Tariq I, Mujtaba A, et al · · 2023 · cited 17× · PMID 38004040 · DOI 10.3390/medicina59111991

Verify or expand the search:

Other recruiting trials for Abdominal Pain

Currently open trials in the same condition.

NCT06381921 — Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain · NA · recruiting
NCT06268717 — GI Alpha-Gal Study · NA · recruiting
NCT05730491 — Online Social Learning Program for Parents With Irritable Bowel Syndrome: Raising Resilient Children · NA · recruiting

Other CENTOGENE GmbH Rostock trials

Trials by the same sponsor.

NCT06040008 — Investigating the Impact of Environmental Factors on the Transcriptomics Profile in Healthy Individuals · completed
NCT05075187 — Epidemiological Study in FRONtoTemporal Dementia · completed
NCT04925804 — Unraveling Genetics of HypoPhosPhatasia (HPP Genetics) · completed
NCT04548921 — Biomarker for Friedreich's Ataxia (BioFridA) · unknown
NCT03866590 — Pyruvate Kinase Deficiency Epidemiological Study (PIECE) · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03558009 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CENTOGENE GmbH Rostock
Last refreshed: 25 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03558009.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing